Cellebrite Di Stock Fundamentals
| CLBT Stock | USD 20.18 1.18 6.21% |
Cellebrite DI fundamentals help investors to digest information that contributes to Cellebrite's financial success or failures. It also enables traders to predict the movement of Cellebrite Stock. The fundamental analysis module provides a way to measure Cellebrite's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellebrite stock.
Cellebrite |
Cellebrite DI Company Operating Margin Analysis
Cellebrite's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cellebrite Operating Margin | 0.18 % |
Most of Cellebrite's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellebrite DI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cellebrite DI has an Operating Margin of 0.182%. This is 102.06% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The operating margin for all United States stocks is 103.3% lower than that of the firm.
Cellebrite DI Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellebrite's current stock value. Our valuation model uses many indicators to compare Cellebrite value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellebrite competition to find correlations between indicators driving Cellebrite's intrinsic value. More Info.Cellebrite DI is rated fifth in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Cellebrite by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cellebrite Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in operating margin category among its peers.
Cellebrite Fundamentals
| Return On Equity | -1.88 | ||||
| Return On Asset | 0.0635 | ||||
| Profit Margin | (0.82) % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 3.72 B | ||||
| Shares Outstanding | 214.84 M | ||||
| Shares Owned By Insiders | 46.79 % | ||||
| Shares Owned By Institutions | 53.01 % | ||||
| Number Of Shares Shorted | 1.51 M | ||||
| Price To Earning | 82.18 X | ||||
| Price To Book | 13.68 X | ||||
| Price To Sales | 10.60 X | ||||
| Revenue | 325.11 M | ||||
| Gross Profit | 219.91 M | ||||
| EBITDA | (64.8 M) | ||||
| Net Income | (81.1 M) | ||||
| Cash And Equivalents | 142.51 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 14.13 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 1.43 X | ||||
| Cash Flow From Operations | 102.06 M | ||||
| Short Ratio | 1.32 X | ||||
| Earnings Per Share | (1.60) X | ||||
| Price To Earnings To Growth | 13.39 X | ||||
| Target Price | 22.43 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 1.5 | ||||
| Market Capitalization | 4.08 B | ||||
| Total Asset | 540.4 M | ||||
| Retained Earnings | 118.14 M | ||||
| Working Capital | 168.26 M | ||||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.